United States· US:73466-0031_2f488a68-7427-857b-e063-6294a90a4c74
HAN SHIN EUNGYOSAN Extract Granules
A medicinal product containing forsythia suspensa fruit; lonicera hypoglauca flower, registered in United States by MISOCOS.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FORSYTHIA SUSPENSA FRUIT; LONICERA HYPOGLAUCA FLOWER
- Manufacturer
- MISOCOS
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc117346600311120 POUCH in 1 PACKAGE (73466-0031-1) / 3.5 g in 1 POUCH
- ndc1173466-0031-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebc6948a-f921-4967-8458-01a23acd3dbb GET /v1/drugs/ebc6948a-f921-4967-8458-01a23acd3dbb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1420; 1420",
"substance": "FORSYTHIA SUSPENSA FRUIT; LONICERA HYPOGLAUCA FLOWER",
"productndc": "73466-0031",
"dosage_form": "GRANULE",
"dea_schedule": null,
"strength_unit": "mg/3.5g; mg/3.5g",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about forsythia suspensa fruit; lonicera hypoglauca flower.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.